After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...
The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...
On the other hand, the nature of its industry means that there will often be solid new reasons to be a bit more cautious ...
Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership ...
Dec 11 (Reuters) - Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's (LLY.N), opens ... FDA declines to approve Zealand Pharma's bowel disease drug December ...
Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to ...
However, given the developmental stage of the products I will focus on the ... to date financial highlights comparing Zealand Pharma vs. Eli Lilly. Please note, Zealand's figures are in DKK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results